How to cite this article: Ganzinelli, M. et al. Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.